{"id":"https://openalex.org/W857041868","doi":"https://doi.org/10.1096/fasebj.29.1_supplement.721.15","title":"Targeted Inhibitors of P\u2010glycoprotein Overcome Multidrug Resistance in Human Cancer Cell Lines","display_name":"Targeted Inhibitors of P\u2010glycoprotein Overcome Multidrug Resistance in Human Cancer Cell Lines","publication_year":2015,"publication_date":"2015-04-01","ids":{"openalex":"https://openalex.org/W857041868","doi":"https://doi.org/10.1096/fasebj.29.1_supplement.721.15","mag":"857041868"},"language":"en","primary_location":{"id":"doi:10.1096/fasebj.29.1_supplement.721.15","doi":"https://doi.org/10.1096/fasebj.29.1_supplement.721.15","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.29.1_supplement.721.15","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045312322","display_name":"Courtney A. Follit","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I178169726","display_name":"Southern Methodist University","ror":"https://ror.org/042tdr378","country_code":"US","type":"education","lineage":["https://openalex.org/I178169726"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Courtney Follit","raw_affiliation_strings":["Department of Biological Sciences The Center for Scientific Computation and the Center for Drug Discovery Design and Delivery (CD4) Southern Methodist University Dallas Texas United States","1Department of Biological Sciences, the Center for Scientific Computation, and the Center for Drug Discovery, Design and Delivery (CD4) Southern Methodist University Dallas Texas United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biological Sciences The Center for Scientific Computation and the Center for Drug Discovery Design and Delivery (CD4) Southern Methodist University Dallas Texas United States","institution_ids":["https://openalex.org/I178169726"]},{"raw_affiliation_string":"1Department of Biological Sciences, the Center for Scientific Computation, and the Center for Drug Discovery, Design and Delivery (CD4) Southern Methodist University Dallas Texas United States","institution_ids":["https://openalex.org/I178169726"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047644737","display_name":"Frances Brewer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I178169726","display_name":"Southern Methodist University","ror":"https://ror.org/042tdr378","country_code":"US","type":"education","lineage":["https://openalex.org/I178169726"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Frances Brewer","raw_affiliation_strings":["Department of Biological Sciences The Center for Scientific Computation and the Center for Drug Discovery Design and Delivery (CD4) Southern Methodist University Dallas Texas United States","1Department of Biological Sciences, the Center for Scientific Computation, and the Center for Drug Discovery, Design and Delivery (CD4) Southern Methodist University Dallas Texas United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biological Sciences The Center for Scientific Computation and the Center for Drug Discovery Design and Delivery (CD4) Southern Methodist University Dallas Texas United States","institution_ids":["https://openalex.org/I178169726"]},{"raw_affiliation_string":"1Department of Biological Sciences, the Center for Scientific Computation, and the Center for Drug Discovery, Design and Delivery (CD4) Southern Methodist University Dallas Texas United States","institution_ids":["https://openalex.org/I178169726"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084263586","display_name":"John G. Wise","orcid":"https://orcid.org/0000-0001-5398-8794","observed_orcids":["https://orcid.org/0000-0001-5398-8794"]},"institutions":[{"id":"https://openalex.org/I178169726","display_name":"Southern Methodist University","ror":"https://ror.org/042tdr378","country_code":"US","type":"education","lineage":["https://openalex.org/I178169726"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Wise","raw_affiliation_strings":["Department of Biological Sciences The Center for Scientific Computation and the Center for Drug Discovery Design and Delivery (CD4) Southern Methodist University Dallas Texas United States","1Department of Biological Sciences, the Center for Scientific Computation, and the Center for Drug Discovery, Design and Delivery (CD4) Southern Methodist University Dallas Texas United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biological Sciences The Center for Scientific Computation and the Center for Drug Discovery Design and Delivery (CD4) Southern Methodist University Dallas Texas United States","institution_ids":["https://openalex.org/I178169726"]},{"raw_affiliation_string":"1Department of Biological Sciences, the Center for Scientific Computation, and the Center for Drug Discovery, Design and Delivery (CD4) Southern Methodist University Dallas Texas United States","institution_ids":["https://openalex.org/I178169726"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5025846620","display_name":"Pia D. Vogel","orcid":"https://orcid.org/0000-0002-8135-4649","observed_orcids":["https://orcid.org/0000-0002-8135-4649"]},"institutions":[{"id":"https://openalex.org/I178169726","display_name":"Southern Methodist University","ror":"https://ror.org/042tdr378","country_code":"US","type":"education","lineage":["https://openalex.org/I178169726"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pia Vogel","raw_affiliation_strings":["Department of Biological Sciences The Center for Scientific Computation and the Center for Drug Discovery Design and Delivery (CD4) Southern Methodist University Dallas Texas United States","1Department of Biological Sciences, the Center for Scientific Computation, and the Center for Drug Discovery, Design and Delivery (CD4) Southern Methodist University Dallas Texas United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biological Sciences The Center for Scientific Computation and the Center for Drug Discovery Design and Delivery (CD4) Southern Methodist University Dallas Texas United States","institution_ids":["https://openalex.org/I178169726"]},{"raw_affiliation_string":"1Department of Biological Sciences, the Center for Scientific Computation, and the Center for Drug Discovery, Design and Delivery (CD4) Southern Methodist University Dallas Texas United States","institution_ids":["https://openalex.org/I178169726"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I178169726"],"apc_list":{"value":3740,"currency":"USD","value_usd":3740},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.01534445,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"29","issue":"S1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1313","display_name":"Molecular Medicine"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.9380000233650208},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.9990000128746033},{"id":"https://openalex.org/keywords/abc-transporters","display_name":"ABC transporters","score":0.9789999723434448},{"id":"https://openalex.org/keywords/atp-binding-domain","display_name":"ATP-binding domain","score":0.7559999823570251},{"id":"https://openalex.org/keywords/atp-hydrolysis-inhibition","display_name":"ATP hydrolysis inhibition","score":0.8700000047683716},{"id":"https://openalex.org/keywords/p-glycoprotein-inhibitors","display_name":"P-glycoprotein inhibitors","score":0.7960000038146973},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.7540000081062317},{"id":"https://openalex.org/keywords/cancer-chemotherapy","display_name":"cancer chemotherapy","score":0.460999995470047},{"id":"https://openalex.org/keywords/molecular-docking","display_name":"molecular docking","score":0.6990000009536743},{"id":"https://openalex.org/keywords/molecular-dynamics-simulation","display_name":"molecular dynamics simulation","score":0.6729999780654907},{"id":"https://openalex.org/keywords/human-cancer-cell-lines","display_name":"human cancer cell lines","score":0.8989999890327454}],"concepts":[{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.7755284309387207},{"id":"https://openalex.org/C44312359","wikidata":"https://www.wikidata.org/wiki/Q286958","display_name":"ATP-binding cassette transporter","level":4,"score":0.7411099076271057},{"id":"https://openalex.org/C2778707650","wikidata":"https://www.wikidata.org/wiki/Q412902","display_name":"P-glycoprotein","level":4,"score":0.7191486954689026},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.5397312641143799},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.5286125540733337},{"id":"https://openalex.org/C149011108","wikidata":"https://www.wikidata.org/wiki/Q652985","display_name":"Transporter","level":3,"score":0.5069518089294434},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.477533221244812},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.47646141052246094},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4488067924976349},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.39400944113731384},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3911515474319458},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.33186280727386475},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3255869150161743},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.28726184368133545},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.17197644710540771},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1339038908481598}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1096/fasebj.29.1_supplement.721.15","doi":"https://doi.org/10.1096/fasebj.29.1_supplement.721.15","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.29.1_supplement.721.15","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320306289","display_name":"Communities Foundation of Texas","ror":"https://ror.org/01tf2gj84"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1590199834","https://openalex.org/W4389024264","https://openalex.org/W1180373670","https://openalex.org/W4389008507","https://openalex.org/W2003692520","https://openalex.org/W4383888119","https://openalex.org/W4386220078","https://openalex.org/W2783056471","https://openalex.org/W3016969414","https://openalex.org/W3091980736"],"abstract_inverted_index":{"Multidrug":[0],"resistance":[1,8],"(MDR),":[2],"the":[3,17,21,36,54,69,89,93,123,144,176,219,229],"intrinsic":[4],"or":[5],"acquired":[6],"simultaneous":[7],"to":[9,20,35,48,67,80,156,160,189,208],"structurally":[10],"and":[11,85,98,107,130,182,210,226,228],"chemically":[12],"unrelated":[13],"drugs,":[14],"is":[15,33,58,137,201],"arguably":[16],"largest":[18],"barrier":[19],"successful":[22],"chemotherapeutic":[23],"treatment":[24],"of":[25,31,38,53,71,96,127,174,193,232],"cancer.":[26],"The":[27],"best":[28],"studied":[29],"mechanism":[30],"MDR":[32,161,177,195],"due":[34],"overexpression":[37],"ABC\u2010transporter":[39],"member":[40],"P\u2010glycoprotein":[41],"(P\u2010gp).":[42],"All":[43],"ABC\u2010transporters":[44,172],"utilize":[45],"ATP":[46,124,135],"hydrolysis":[47,136],"actively":[49],"export":[50],"substrates":[51,63],"out":[52],"cell,":[55],"but":[56],"P\u2010gp":[57,82,97,119],"exceptional":[59],"in":[60,196],"that":[61,117,166],"its":[62],"are":[64,179,185],"diverse":[65],"enough":[66],"include":[68],"majority":[70,90],"clinically":[72],"relevant":[73],"chemotherapeutics.":[74],"Researchers":[75],"have":[76,133,149],"searched":[77],"for":[78,83,153,222],"drugs":[79],"inhibit":[81,118],"decades":[84],"largely":[86],"failed":[87],"because":[88],"interacted":[91],"with":[92],"drug\u2010binding":[94],"domain":[95,126],"were":[99],"themselves":[100],"transported.":[101],"Using":[102],"targeted":[103],"molecular":[104],"dynamic":[105],"simulations":[106],"massively":[108],"parallel":[109],"drug":[110,158],"docking":[111],"studies,":[112],"we":[113,148],"identified":[114],"novel":[115,141],"compounds":[116,152,184],"by":[120,139,203],"specifically":[121],"targeting":[122],"binding":[125],"P\u2010gp.":[128,168],"Biochemical":[129],"biophysical":[131],"studies":[132,145],"confirmed":[134],"inhibited":[138],"these":[140,151],"compounds.":[142],"In":[143],"reported":[146],"here,":[147],"evaluated":[150,181],"their":[154],"ability":[155],"restore":[157],"sensitivity":[159],"human":[162,197],"cancer":[163],"cell":[164],"lines":[165],"overexpress":[167],"Effects":[169],"on":[170],"other":[171],"capable":[173,192],"conferring":[175],"phenotype":[178],"being":[180],"lead":[183],"undergoing":[186],"chemical":[187],"optimization":[188],"develop":[190],"co\u2010therapeutics":[191],"reversing":[194],"cancers.":[198],"This":[199],"work":[200],"supported":[202],"NIH":[204],"NIGMS":[205],"[Grant":[206],"1R15\u2010GM094771\u201001A1]":[207],"PDV":[209],"JGW,":[211],"SMU":[212,215,220],"Research":[213,217],"Council,":[214,218],"Dean's":[216],"Center":[221],"Drug":[223],"Discovery,":[224],"Design":[225],"Delivery,":[227],"Communities":[230],"Foundation":[231],"Texas,":[233],"Dallas.":[234]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2019,"cited_by_count":1}],"updated_date":"2026-08-21T09:56:20.448147","created_date":"2016-06-24T00:00:00"}